Active ingredientOspemifeneCat. No. P-O042-001CAS 128607-22-7Family · Pharmaceutical analytical standards
Ospemifene
A selective oestrogen receptor modulator (SERM) for the symptoms of vulvovaginal atrophy in menopause, such as painful intercourse, approved in the United States in 2013 and in Europe in 2015. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?One of its chemical names, deaminohydroxytoremifene, reveals its kinship with toremifene. Like every SERM it has two faces: it mimics oestrogen in vaginal tissue, but in the laboratory it blocks oestrogen's effect on breast cancer cells.
Go to the active ingredient →Active ingredientOspemifeneCat. No. P-O042-001CAS 128607-22-7
MetaboliteOspemifene GlucuronideCat. No. P-O042-002
MetaboliteOspemifene Metabolite 1Cat. No. P-O042-003CAS 128585-02-4
Isotopically labelledOspemifene-d4Cat. No. P-O042-004
ImpurityOspemifene Impurity 1Cat. No. P-O042-005CAS 89778-42-7
ImpurityOspemifene Impurity 2Cat. No. P-O042-006CAS 89778-41-6
ImpurityFispemifeneCat. No. P-O042-007CAS 341524-89-8
ImpurityIodo OspemifeneCat. No. P-O042-008
ImpurityOspemifene Dimer ImpurityCat. No. P-O042-009
ImpurityOspemifene E-IsomerCat. No. P-O042-010CAS 238089-02-6
ImpurityOspemifene Impurity 3Cat. No. P-O042-011CAS 341527-08-0
ImpurityVinyl OspemifeneCat. No. P-O042-012No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.